Literature DB >> 19036880

Hexosamine biosynthesis pathway flux contributes to insulin resistance via altering membrane phosphatidylinositol 4,5-bisphosphate and cortical filamentous actin.

Padma Bhonagiri1, Guruprasad R Pattar, Emily M Horvath, Kirk M Habegger, Alicia M McCarthy, Jeffrey S Elmendorf.   

Abstract

We recently found that plasma membrane phosphatidylinositol 4,5-bisphosphate (PIP(2))-regulated filamentous actin (F-actin) polymerization was diminished in hyperinsulinemic cell culture models of insulin resistance. Here we delineated whether increased glucose flux through the hexosamine biosynthesis pathway (HBP) causes the PIP(2)/F-actin dysregulation and insulin resistance induced by hyperinsulinemia. Increased HBP activity was detected in 3T3-L1 adipocytes cultured under conditions closely resembling physiological hyperinsulinemia (5 nm insulin for 12 h) and in cells where HBP activity was amplified by 2 mm glucosamine (GlcN). Both the physiological hyperinsulinemia and experimental GlcN challenge induced comparable losses of PIP(2) and F-actin. In addition to protecting against the insulin-induced membrane/cytoskeletal abnormality and insulin-resistant state, exogenous PIP(2) corrected the GlcN-induced insult on these parameters. Moreover, in accordance with HBP flux directly weakening PIP(2)/F-actin structure, inhibition of the rate-limiting HBP enzyme (glutamine:fructose-6-phosphate amidotransferase) restored PIP(2)-regulated F-actin structure and insulin responsiveness. Conversely, overexpression of glutamine:fructose-6-phosphate amidotransferase was associated with a loss of detectable plasma membrane PIP(2) and insulin sensitivity. A slight decrease in intracellular ATP resulted from amplifying HBP by hyperinsulinemia and GlcN. However, experimental maintenance of the intracellular ATP pool under both conditions with inosine did not reverse the PIP(2)/F-actin-based insulin-resistant state. Furthermore, less invasive challenges with glucose, in the absence of insulin, also led to PIP(2)/F-actin dysregulation. Accordingly, we suggest that the functionality of cell systems dependent on PIP(2) and/or F-actin status, such as the glucose transport system, can be critically compromised by inappropriate HBP activity.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19036880      PMCID: PMC2659275          DOI: 10.1210/en.2008-1102

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  60 in total

Review 1.  Insulin signaling and the regulation of glucose transport.

Authors:  Louise Chang; Shian-Huey Chiang; Alan R Saltiel
Journal:  Mol Med       Date:  2004 Jul-Dec       Impact factor: 6.354

2.  Role of p21ras in insulin-stimulated glucose transport in 3T3-L1 adipocytes.

Authors:  S F Hausdorff; J V Frangioni; M J Birnbaum
Journal:  J Biol Chem       Date:  1994-08-26       Impact factor: 5.157

3.  Discovery of a metabolic pathway mediating glucose-induced desensitization of the glucose transport system. Role of hexosamine biosynthesis in the induction of insulin resistance.

Authors:  S Marshall; V Bacote; R R Traxinger
Journal:  J Biol Chem       Date:  1991-03-15       Impact factor: 5.157

4.  Protective effect of phosphatidylinositol 4,5-bisphosphate against cortical filamentous actin loss and insulin resistance induced by sustained exposure of 3T3-L1 adipocytes to insulin.

Authors:  Guoli Chen; Priya Raman; Padma Bhonagiri; Andrew B Strawbridge; Guruprasad R Pattar; Jeffrey S Elmendorf
Journal:  J Biol Chem       Date:  2004-07-23       Impact factor: 5.157

5.  Increasing neutrophil F-actin corrects CD11b exposure in Type 2 diabetes.

Authors:  A Advani; S M Marshall; T H Thomas
Journal:  Eur J Clin Invest       Date:  2004-05       Impact factor: 4.686

6.  Hyperglycemia decreases glucose uptake in type I diabetes.

Authors:  H Yki-Järvinen; E Helve; V A Koivisto
Journal:  Diabetes       Date:  1987-08       Impact factor: 9.461

7.  Correction of hyperglycemia with phlorizin normalizes tissue sensitivity to insulin in diabetic rats.

Authors:  L Rossetti; D Smith; G I Shulman; D Papachristou; R A DeFronzo
Journal:  J Clin Invest       Date:  1987-05       Impact factor: 14.808

8.  Pretranslational suppression of a glucose transporter protein causes insulin resistance in adipocytes from patients with non-insulin-dependent diabetes mellitus and obesity.

Authors:  W T Garvey; L Maianu; T P Huecksteadt; M J Birnbaum; J M Molina; T P Ciaraldi
Journal:  J Clin Invest       Date:  1991-03       Impact factor: 14.808

9.  O-linked glycoproteins of the nuclear pore complex interact with a cytosolic factor required for nuclear protein import.

Authors:  R Sterne-Marr; J M Blevitt; L Gerace
Journal:  J Cell Biol       Date:  1992-01       Impact factor: 10.539

10.  Nuclear pore complex glycoproteins contain cytoplasmically disposed O-linked N-acetylglucosamine.

Authors:  G D Holt; C M Snow; A Senior; R S Haltiwanger; L Gerace; G W Hart
Journal:  J Cell Biol       Date:  1987-05       Impact factor: 10.539

View more
  4 in total

1.  O-GlcNAc Modification: Friend or Foe in Diabetic Cardiovascular Disease.

Authors:  Udayakumar Karunakaran; Nam Ho Jeoung
Journal:  Korean Diabetes J       Date:  2010-08-31

Review 2.  Hexosamine flux, the O-GlcNAc modification, and the development of insulin resistance in adipocytes.

Authors:  Chin Fen Teo; Edith E Wollaston-Hayden; Lance Wells
Journal:  Mol Cell Endocrinol       Date:  2009-09-30       Impact factor: 4.102

3.  Involvement of signaling molecules on na/h exchanger-1 activity in human monocytes.

Authors:  Maria Sarigianni; Apostolos Tsapas; Dimitri P Mikhailidis; Martha Kaloyianni; George Koliakos; Konstantinos Paletas
Journal:  Open Cardiovasc Med J       Date:  2010-09-28

Review 4.  The relationship between phospholipids and insulin resistance: From clinical to experimental studies.

Authors:  Wenguang Chang; Grant M Hatch; Yu Wang; Fei Yu; Man Wang
Journal:  J Cell Mol Med       Date:  2018-11-06       Impact factor: 5.310

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.